FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064687 [Registered on: 22/03/2024] Trial Registered Prospectively
Last Modified On: 06/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Tiladi Churna (orally) with Vidangadi Lepa in the Management of Dadru Kushtha(Fungal Infection)  
Scientific Title of Study   Efficacy of Tiladi Churna (orally) with Vidangadi Lepa in the Management of Dadru Kushtha- a Open Label Randomised Standard Control Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tadhani Piyush Lakhmanbhai 
Designation  MD Scholar, Department of Roga Nidana Evum Vikriti Vigyana 
Affiliation  All India Institute Of Ayurveda 
Address  Department of Roga Nidana Evum Vikriti Vigyana, 3rd floor, Academic block, Block C, All India Institute Of Ayurveda, Gautampuri, Sarita vihar, Mathura road, New Delhi

New Delhi
DELHI
110076
India 
Phone  9998828083  
Fax    
Email  piyushtadhani555@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Anand B More 
Designation  Professor and Head Of Department 
Affiliation  All India Institute Of Ayurveda 
Address  Department of Roga Nidana Evum Vikriti Vigyana, 3rd floor, Academic block, Block C, All India Institute Of Ayurveda, Gautampuri, Sarita vihar, Mathura road, New Delhi

New Delhi
DELHI
110076
India 
Phone  9422025732  
Fax    
Email  drmoreanand@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tadhani Piyush Lakhmanbhai 
Designation  MD Scholar, Department of Roga Nidana Evum Vikriti Vigyana 
Affiliation  All India Institute Of Ayurveda 
Address  Department of Roga Nidana Evum Vikriti Vigyana, 3rd floor, Academic block, Block C, All India Institute Of Ayurveda, Gautampuri, Sarita vihar, Mathura road, New Delhi

New Delhi
DELHI
110076
India 
Phone  9998828083  
Fax    
Email  piyushtadhani555@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda 
 
Primary Sponsor  
Name  All India Institute Of Ayurveda 
Address  All India Institute Of Ayurveda, Gautampuri, Sarita Vihar, Mathura road, New Delhi 110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tadhani Piyush Lakhmanbhai  All India Institute Of Ayurveda  Department of Roga Nidana Evum Vikriti Vigyan, OPD no. 8, Ground Floor, Hospital block, All India Institute Of Ayurveda, Gautampuri, Sarita Vihar, Mathura Road, New Delhi 110076
New Delhi
DELHI 
9998828083

piyushtadhani555@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,All India Institute of Ayurveda,New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:B359||Dermatophytosis, unspecified. Ayurveda Condition: DADRU-KUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-lepa, लेप (Procedure Reference: Yogaratnakar, Procedure details: Two times in a day Procedure – •Clean the affected area with cotton soaked in water. •Apply sufficient amount of Lepa. •After 2 hours, the Lepa will be cleaned with water with the help of cotton swab. )
(1) Medicine Name: Tiladi churna, Reference: Chakradatta, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: od, Duration: 30 Days
2Comparator Arm (Non Ayurveda)-Terbinafine ointment•Terbinafine ointment 1% w/w will be used for the study. Two times in a day Procedure - •Clean and dry the affected skin properly. •Then, apply a thin layer of Terbinafine ointment on and around the affected skin gently. •Do not cover the area after applying the cream. •Avoid getting the medicine into the eyes, nose or mouth.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient with classical sign and symptoms of Dadru Kushtha
Patients willing to participate.  
 
ExclusionCriteria 
Details  Patients suffering from Systemic Disorders, uncontrolled DM, HIV, Hepatitis- B, malignancy.
Cases of Burn.
Known cases of any other skin disease.
Any allergic condition related to skin and hypersensitivity to any medicine.
Pregnant and lactating women
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Resolution in the sign and symptoms of Dadru kushtha  Assessment of sign and symptoms of dadru kushtha at baseline,30th day,60th day  
 
Secondary Outcome  
Outcome  TimePoints 
•To observe & determine the growth of fungus in Dadru kushtha by culture study.
•To observe the Antifungal effect of Vidangadi lepa through sensitivity
 
1.Identification of fungus by microscopic examination using KOH(potassium hydroxide)10% at baseline
2.Assessment of Antifungal effect of Vidangadi lepa through sensitivity at baseline
 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

There are eighteen types of Kushtha Roga which are classified into Maha Kushtha and Kshudra Kushtha. Dadru is classified as a Kshudra Kushtha by ’Acharya Charaka’ and MahaKushtha  by  ’Acharya  Sushruta’. Mithya Ahara Vihar is the main cause of Kushtha Roga.

AIM:

a) To compare the efficacy of Tiladi churna (orally) with Vidangadi Lepa (L/A)  and Tiladi churna (orally) with Terbinafine Ointment (L/A)  in management of Dadru Kushtha .

b) To determine Anti-fungal effect of Vidangadi lepa in Dadru Kustha through Sensitivity.

 

OBJECTIVES:

PRIMARY:

•         To compare the efficacy of Vidangadi lepa and Terbinafine Ointment externally with Tiladi churna internally in both group in the management of Dadru Kushtha.

 

SECONDARY:

•         To observe and determine the growth of fungus in Dadru kushtha by culture study.

•         To observe the Antifungal effect of Vidangadi lepa  through sensitivity.

 

 
Close